NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
NOVO NORDISK A S
Financials through fiscal 2025, year ended Dec 31, 2025
$38.42−0.41 (-1.06%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Dec 31, 2025
Total debt
142.98B DKK
24.03B DKK due within a year
Net debt
116.51B DKK
After 26.46B DKK of cash
Implied interest rate
5.24%
FY2025 interest ÷ average debt
Interest coverage
18.8×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, DKK
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Novo Nordisk A S's annual report. Trading prices and yields need FINRA TRACE data.